PLSE Q4 2023 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

PLSEPulse Biosciences, Inc.

$1B

Q4 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$0+100.0% YoY

Gross Profit

$0

Operating Income

-$13M

Net Income

-$12M

EPS (Diluted)

$-0.22

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$59M

Total Liabilities

$15M

Stockholders' Equity

$44M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	-$9,000	+100.0%
Gross Profit	$0	-$1M	+100.0%
Operating Income	-$13M	-$9M	-43.3%
Net Income	-$12M	-$9M	-29.7%